Berkley W R Corp grew its holdings in shares of Aimei Health Technology Co., Ltd. (NASDAQ:AFJK – Free Report) by 23.6% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 425,361 shares of the company’s stock after acquiring an additional 81,235 shares during the period. Berkley W R Corp owned 6.95% of Aimei Health Technology worth $4,704,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Polar Asset Management Partners Inc. acquired a new stake in Aimei Health Technology during the first quarter worth approximately $110,000. Wellspring Financial Advisors LLC acquired a new stake in shares of Aimei Health Technology during the 2nd quarter worth approximately $133,000. Clear Street LLC grew its position in shares of Aimei Health Technology by 63.8% during the 2nd quarter. Clear Street LLC now owns 39,525 shares of the company’s stock worth $441,000 after buying an additional 15,399 shares during the period. Quarry LP increased its stake in shares of Aimei Health Technology by 4.7% in the 1st quarter. Quarry LP now owns 157,081 shares of the company’s stock valued at $1,729,000 after acquiring an additional 7,081 shares in the last quarter. Finally, Crossingbridge Advisors LLC acquired a new position in shares of Aimei Health Technology during the 2nd quarter valued at $2,147,000. 45.58% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
Separately, Weiss Ratings restated a “sell (d+)” rating on shares of Aimei Health Technology in a report on Monday. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Aimei Health Technology currently has a consensus rating of “Sell”.
Aimei Health Technology Trading Down 17.2%
Aimei Health Technology stock opened at $29.67 on Friday. The firm has a market capitalization of $181.58 million, a price-to-earnings ratio of 141.29 and a beta of 0.03. The firm’s fifty day moving average price is $14.13 and its two-hundred day moving average price is $12.22. Aimei Health Technology Co., Ltd. has a 1-year low of $6.75 and a 1-year high of $98.15.
Aimei Health Technology (NASDAQ:AFJK – Get Free Report) last posted its earnings results on Tuesday, November 18th. The company reported $0.06 EPS for the quarter.
About Aimei Health Technology
Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors.
Featured Stories
- Five stocks we like better than Aimei Health Technology
- What Are Dividend Challengers?
- Synopsys Sees Bullish Shift as Ansys Integration Drives Growth
- Options Trading – Understanding Strike Price
- The Best Holiday Present You Can Give Yourself? Costco Stock
- Airline Stocks – Top Airline Stocks to Buy Now
- Why Zscaler Stock Could Be Ready to Bounce After a 30% Selloff
Receive News & Ratings for Aimei Health Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aimei Health Technology and related companies with MarketBeat.com's FREE daily email newsletter.
